UPDATE: Danaher Buying Beckman Coulter for $6.8B | GenomeWeb

The story has been updated to include information and comments from a conference call Danaher held this morning.

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Danaher has agreed to buy Beckman Coulter in a deal valued at $6.8 billion, the two companies announced today.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.